Larimar Therapeutics, Inc. (LRMR) Earnings Call Transcripts

10 earnings calls from May 2021 to June 29, 2026

NasdaqGM US Health Care Biotechnology

About Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc. (LRMR) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqGM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 10 calls on record spanning May 11, 2021 to June 29, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 10 Larimar Therapeutics, Inc. earnings call transcripts on record, spanning May 11, 2021 to June 29, 2026. Based on this history, Larimar Therapeutics, Inc. reports semi-annually. The most recent call on file is dated June 29, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
LRMR
Exchange
NasdaqGM
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
10
First call
May 11, 2021
Most recent
June 29, 2026
Reporting cadence
semi-annually
Quarter Date
Special Calls Jun 29, 2026 Read transcript →
Company Conference Presentations Jan 14, 2026 Read transcript →
Special Calls Sep 29, 2025 Read transcript →
Special Calls Dec 16, 2024 Read transcript →
Special Calls Feb 12, 2024 Read transcript →
Special Calls Jul 25, 2023 Read transcript →
Q1 FY2023 May 15, 2023 Read transcript →
Special Calls Sep 14, 2022 Read transcript →
Company Conference Presentations Sep 9, 2021 Read transcript →
Special Calls May 11, 2021 Read transcript →